IMPV - Imperva - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $6.62. This is a potential upside of $6.62 (0%) from yesterday's end of day stock price of $0.

Imperva's activity chart (see below) currently has 60 price targets and 44 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.32% with an average time for these price targets to be met of 263.63 days.

Most recent stock forecast was given by MATTHEW HEDBERG from RBC on 06-Nov-2018. First documented stock forecast 04-Sep-2013.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

56

$0.26 (0.47%)

55.75

5 years 5 months 12 days ago

3/4 (75%)

$0.35 (0.63%)

276

Hold

60

5 years 8 months 22 days ago

3/7 (42.86%)

$7.8 (14.94%)

384

Buy

65

$9.26 (16.61%)

5 years 9 months 8 days ago

0/2 (0%)

$13.3 (25.73%)

67

$11.26 (20.20%)

61

5 years 10 months 4 days ago

3/6 (50%)

$14.55 (27.74%)

537

Buy

55

$-0.74 (-1.33%)

55

6 years 6 days ago

8/8 (100%)

$8.65 (18.66%)

267

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMPV (Imperva) average time for price targets to be met?

On average it took 263.63 days on average for the stock forecasts to be realized with a an average price target met ratio 59.32

Which analyst has the current highest performing score on IMPV (Imperva) with a proven track record?

JONATHAN RUYKHAVER

Which analyst has the current lower performing score on IMPV (Imperva) with a proven track record?

ROB OWENS

Which analyst has the most public recommendations on IMPV (Imperva)?

Jonathan Ruykhaver works at CANTOR FITZGERALD and has 38 price targets and 19 ratings on IMPV

Which analyst is the currently most bullish on IMPV (Imperva)?

Jonathan Ruykhaver with highest potential upside - $11.26

Which analyst is the currently most reserved on IMPV (Imperva)?

Imtiaz Koujalgi with lowest potential downside - -$12.74

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?